• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成素样蛋白4的寡聚化及调控性蛋白水解加工

Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4.

作者信息

Ge Hongfei, Yang Guoqing, Huang Lu, Motola Daniel L, Pourbahrami Tiffany, Li Cai

机构信息

Touchstone Center for Diabetes Research and Departments of Physiology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8854, USA.

出版信息

J Biol Chem. 2004 Jan 16;279(3):2038-45. doi: 10.1074/jbc.M307583200. Epub 2003 Oct 21.

DOI:10.1074/jbc.M307583200
PMID:14570927
Abstract

Angiopoietin-like protein 4 (Angptl4) is a recently identified circulating protein expressed primarily in adipose tissue and liver. Also known as peroxisome proliferator-activated receptor (PPAR)-gamma angiopoietin-related, fasting induced adipose factor, and hepatic fibrinogen/angiopoietin-related protein, recombinant Angptl4 causes increase of plasma very low density lipoprotein levels by inhibition of lipoprotein lipase activity. Similar to angiopoietins and other angiopoietin-like proteins, Angptl4 contains an amino-terminal coiled-coil domain and a carboxyl-terminal fibrinogen-like domain. We report here that Angptl4 is evolutionarily conserved among several mammalian species and that full-length Angptl4 protein is an oligomer containing intermolecular disulfide bonds. Oligomerized Angptl4 undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. Angptl4's N-terminal coiled-coil domain mediates its oligomerization, which by itself is sufficient to form higher order oligomeric structure. Adenovirus-mediated overexpression of Angptl4 in 293 cells shows that conversion of full-length, oligomerized Angptl4 is mediated by a cell-associated protease activity induced by serum. These findings demonstrate a novel property of angiopoietin-like proteins and suggest that oligomerization and proteolytic processing of Angptl4 may regulate its biological activities in vivo.

摘要

血管生成素样蛋白4(Angptl4)是一种最近发现的循环蛋白,主要在脂肪组织和肝脏中表达。它也被称为过氧化物酶体增殖物激活受体(PPAR)-γ血管生成素相关蛋白、禁食诱导脂肪因子和肝纤维蛋白原/血管生成素相关蛋白,重组Angptl4通过抑制脂蛋白脂肪酶活性导致血浆极低密度脂蛋白水平升高。与血管生成素和其他血管生成素样蛋白相似,Angptl4包含一个氨基末端卷曲螺旋结构域和一个羧基末端纤维蛋白原样结构域。我们在此报告,Angptl4在几种哺乳动物物种中具有进化保守性,并且全长Angptl4蛋白是一种含有分子间二硫键的寡聚体。寡聚化的Angptl4经过蛋白水解加工以释放其羧基纤维蛋白原样结构域,该结构域以单体形式循环。Angptl4的氨基末端卷曲螺旋结构域介导其寡聚化,其本身足以形成更高阶的寡聚结构。腺病毒介导的Angptl4在293细胞中的过表达表明,全长、寡聚化的Angptl4的转化是由血清诱导的细胞相关蛋白酶活性介导的。这些发现证明了血管生成素样蛋白的一种新特性,并表明Angptl4的寡聚化和蛋白水解加工可能在体内调节其生物学活性。

相似文献

1
Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4.血管生成素样蛋白4的寡聚化及调控性蛋白水解加工
J Biol Chem. 2004 Jan 16;279(3):2038-45. doi: 10.1074/jbc.M307583200. Epub 2003 Oct 21.
2
Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4.血管生成素样蛋白4的寡聚化状态依赖性高脂血症效应
J Lipid Res. 2004 Nov;45(11):2071-9. doi: 10.1194/jlr.M400138-JLR200. Epub 2004 Aug 1.
3
Differential regulation and properties of angiopoietin-like proteins 3 and 4.血管生成素样蛋白3和4的差异调节与特性
J Lipid Res. 2005 Jul;46(7):1484-90. doi: 10.1194/jlr.M500005-JLR200. Epub 2005 May 1.
4
The C-terminal fibrinogen-like domain of angiopoietin-like 4 stimulates adipose tissue lipolysis and promotes energy expenditure.血管生成素样蛋白4的C末端纤维蛋白原样结构域刺激脂肪组织脂解并促进能量消耗。
J Biol Chem. 2017 Sep 29;292(39):16122-16134. doi: 10.1074/jbc.M117.803973. Epub 2017 Aug 24.
5
Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.血管生成素样蛋白4改变脂蛋白脂肪酶与其内皮细胞转运体GPIHBP1之间的相互作用。
J Biol Chem. 2015 May 8;290(19):11865-77. doi: 10.1074/jbc.M114.623769. Epub 2015 Mar 25.
6
A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.血管生成素样蛋白4氨基末端卷曲螺旋结构域内的一个高度保守基序通过破坏脂蛋白脂肪酶的二聚化赋予其对该酶的抑制作用。
J Biol Chem. 2009 May 1;284(18):11942-52. doi: 10.1074/jbc.M809802200. Epub 2009 Feb 26.
7
Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4.血管生成素样蛋白4羧基末端对Raf/MEK/ERK信号级联的抑制及对血管生成的抑制作用
Arterioscler Thromb Vasc Biol. 2008 May;28(5):835-40. doi: 10.1161/ATVBAHA.107.157776. Epub 2008 Mar 13.
8
Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.血管生成素样蛋白4(ANGPTL4,禁食诱导脂肪因子)是糖皮质激素受体的直接靶点,并参与糖皮质激素调节的甘油三酯代谢。
J Biol Chem. 2009 Sep 18;284(38):25593-601. doi: 10.1074/jbc.M109.025452. Epub 2009 Jul 23.
9
Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.脂肪酸与血管生成素样蛋白 4 的 N 端结构域紧密结合,并调节其与脂蛋白脂肪酶的相互作用。
J Biol Chem. 2012 Aug 24;287(35):29739-52. doi: 10.1074/jbc.M111.303529. Epub 2012 Jul 7.
10
Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.肌肉衍生的血管生成素样蛋白4由脂肪酸通过过氧化物酶体增殖物激活受体(PPAR)-δ诱导产生,并且在人类中具有代谢相关性。
Diabetes. 2009 Mar;58(3):579-89. doi: 10.2337/db07-1438. Epub 2008 Dec 15.

引用本文的文献

1
ANGPTL4: A Comprehensive Review of 25 Years of Research.血管生成素样蛋白4:25年研究综述
Cancers (Basel). 2025 Jul 16;17(14):2364. doi: 10.3390/cancers17142364.
2
Adipose Factor ANGPTL4: Its Role in Aging Mechanisms and Associated Diseases.脂肪因子ANGPTL4:其在衰老机制及相关疾病中的作用
Clin Interv Aging. 2025 Jun 28;20:911-929. doi: 10.2147/CIA.S522049. eCollection 2025.
3
Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target.血管生成素样蛋白4在肾脏疾病中的失调:一种有前景的生物标志物和治疗靶点。
Front Pharmacol. 2025 Jan 7;15:1475198. doi: 10.3389/fphar.2024.1475198. eCollection 2024.
4
Angiopoietin-like 4 protects against endothelial dysfunction during bacterial sepsis.血管生成素样蛋白 4 可防止细菌败血症期间的内皮功能障碍。
Nat Microbiol. 2024 Sep;9(9):2434-2447. doi: 10.1038/s41564-024-01760-4. Epub 2024 Aug 5.
5
Identification of angiogenesis-related genes and molecular subtypes for psoriasis based on random forest algorithm.基于随机森林算法的银屑病血管生成相关基因和分子亚型的鉴定。
Clin Exp Immunol. 2024 Oct 16;218(2):199-212. doi: 10.1093/cei/uxae052.
6
Single-cell transcriptomic profiling of heart reveals ANGPTL4 linking fibroblasts and angiogenesis in heart failure with preserved ejection fraction.心脏单细胞转录组分析揭示血管生成素样蛋白4在射血分数保留的心力衰竭中连接成纤维细胞与血管生成。
J Adv Res. 2025 Feb;68:215-230. doi: 10.1016/j.jare.2024.02.006. Epub 2024 Feb 10.
7
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.ANGPTL4 是 HCV 诱导外周胰岛素抵抗的潜在驱动因素。
Sci Rep. 2023 Apr 25;13(1):6767. doi: 10.1038/s41598-023-33728-5.
8
Lung pericytes as mediators of inflammation.肺周细胞作为炎症的介质。
Am J Physiol Lung Cell Mol Physiol. 2023 Jul 1;325(1):L1-L8. doi: 10.1152/ajplung.00354.2022. Epub 2023 May 2.
9
Dantrolene inhibits lysophosphatidylcholine-induced valve interstitial cell calcific nodule formation blockade of the ryanodine receptor.丹曲林抑制溶血磷脂酰胆碱诱导的瓣膜间质细胞钙化结节形成——ryanodine受体的阻断作用。
Front Cardiovasc Med. 2023 Mar 30;10:1112965. doi: 10.3389/fcvm.2023.1112965. eCollection 2023.
10
Primary tumor-derived systemic nANGPTL4 inhibits metastasis.原发肿瘤衍生的系统性 nANGPTL4 抑制转移。
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20202595. Epub 2022 Oct 21.